Internal Medicine

• 

  All Medical News

  EMA Highlights: Europe to support Zika trials

  Written by Gary Finnegan | 16 Feb 2016

  by Gary Finnegan: The European Medicines Agency has set up a task force on Zika virus in an effort to accelerate the development of new medicines and vaccines… read more.

• 

  All Medical News

  ASH 2015: Building good combinations. Professor Sagar Lonial (Emory University School of Medicine, Atlanta, USA) discusses the benefits of building good combinations early on in therapy and the impact that newly available triplet oral therapy will have on patients with myeloma

  Written by Lorraine Carolan | 15 Feb 2016

• 

  All Medical News

  ASH 2015: Good news for patients from ASH! Erik Low (Chief Executive Myeloma UK), Professor Antonio Palumbo (University of Torino, Italy), Professor Paul Richardson (Harvard Medical School, Boston, USA) and Dr Shaji Kumar (Mayo Clinic, Rochester, USA) discuss the things they will take home to their myeloma patients folloing ASH 2015

  Written by Lorraine Carolan | 12 Feb 2016

• 

  All Medical News

  ASH 2015: Video Interview by Esther Drain. CDF changes affecting myeloma patients. Professor Graham Jackson (NCCC, Newcastle Hospitals Trust, UK) and Erik Low (Chief Executive Myeloma UK) discuss recent changes in the CDF and how they affect myeloma patients.

  Written by Lorraine Carolan | 11 Feb 2016

• 

  All Medical News

  ASH 2015: We ask Professor Sagar Lonial (Emory University School of Medicine, Atlanta, USA) what the role of PET/CT is as a measure of MRD post ASCT and ask Professor Antonio Palumbo (University of Torino, Italy) and Professor Graham Jackson (NCCC, Newcastle Hospitals Trust, UK) whether MRD measurement is ready for clinical use

  Written by Lorraine Carolan | 10 Feb 2016

  Role of minimal residual disease in treatment tailoring divides experts by Thomas R. Collins Minimal residual disease (MRD) is a guide for tailoring multiple myeloma whose time has… read more.

• 

  All Medical News

  ASH 2015: Video Interview by Esther Drain. Myeloma XI initial response data at ASH. Professor Graham Jackson (NCCC, Newcastle Hospitals Trust, UK) discusses the initial response data from Myeloma XI and whether early intensive therapy is the way forward in managing myeloma, with comment also from Professor Sagar Lonial (Emory University School of Medicine, Atlanta, USA).

  Written by Lorraine Carolan | 9 Feb 2016

• 

  All Medical News

  ASH 2015: Ernest Beutler Lecture Prize: Award-winners trace history of proteasome and its starring role in MM treatment: Interview with Alfred Goldberg, PhD, Professor of Cell Biology at Harvard Medical School, and Paul Richardson, MD, Professor of Medicine at the Dana-Farber Cancer Center

  Written by Lorraine Carolan | 8 Feb 2016

  by Thomas R. Collins: Standing at the center of a decade and a half of stunning advancements in the treatment of multiple myeloma is the ubiquitin proteasome pathway… read more.

• 

  All Medical News

  ASH 2015: Myeloma X (intensive) trial update: Professor Gordon Cook (Leeds Teaching Hospitals, UK) gives an update on Myeloma X and discusses the role of transplant in myeloma in the age of novel agents

  Written by Lorraine Carolan | 5 Feb 2016

• 

  All Medical News

  ASH 2015: Professor Antonio Palumbo (University of Torino, Italy), Dr Shaji Kumar (Mayo Clinic, Rochester, USA), Professor Graham Jackson (NCCC, Newcastle Hospitals Trust, UK) and Professor Gordon Cook (Leeds Teaching Hospitals, UK) give their highlights.

  Written by Lorraine Carolan | 4 Feb 2016

• 

  All Medical News

  Exercise helps prevent low back pain

  Written by Bruce Sylvester | 3 Feb 2016

  by Bruce Sylvester: Results from a meta-analysis of relevant studies suggest that exercise, alone or in combination with education, reduces the risk of low back pain. The findings… read more.

• 

  All Medical News

  Increased risk of diabetes appears in women with sleep problems

  Written by Bruce Sylvester | 2 Feb 2016

  by Bruce Sylvester: Women who have problems sleeping are at an increased risks of developing type 2 diabetes, researchers reported on January 28, 2016 in Diabetologia.

• 

  All Medical News

  Ozone raises risk of acute respiratory disease syndrome in critically ill patients

  Written by Bruce Sylvester | 1 Feb 2016

  by Bruce Sylvester: Ozone exposure appears to be associated with acute respiratory disease syndrome (ARDS) in some critically ill patients, according to research published on Dec. 17, 2015… read more.